Biovest CEO and Sr. Vice President Discuss Global Marketing of BiovaxID

Biovest International, Inc. (OTCQB: BVTI) announced that Biovest is seeking marketing approval in Canada for BiovaxID®, its personalized cancer vaccine for the treatment of follicular non-Hodgkin’s lymphoma.

Read more »